Marchelek, E.M.; Nemeth, A.; Mohak, S.; Varga, K.; Lukacsi, S.; Fabian, Z.
Dendritic Cell Therapy in Immuno-Oncology: A Potentially Key Component of Anti-Cancer Immunotherapies. Cancers 2026, 18, 123.
https://doi.org/10.3390/cancers18010123
AMA Style
Marchelek EM, Nemeth A, Mohak S, Varga K, Lukacsi S, Fabian Z.
Dendritic Cell Therapy in Immuno-Oncology: A Potentially Key Component of Anti-Cancer Immunotherapies. Cancers. 2026; 18(1):123.
https://doi.org/10.3390/cancers18010123
Chicago/Turabian Style
Marchelek, Emilia Marta, Afrodite Nemeth, Sidhesh Mohak, Kamilla Varga, Szilvia Lukacsi, and Zsolt Fabian.
2026. "Dendritic Cell Therapy in Immuno-Oncology: A Potentially Key Component of Anti-Cancer Immunotherapies" Cancers 18, no. 1: 123.
https://doi.org/10.3390/cancers18010123
APA Style
Marchelek, E. M., Nemeth, A., Mohak, S., Varga, K., Lukacsi, S., & Fabian, Z.
(2026). Dendritic Cell Therapy in Immuno-Oncology: A Potentially Key Component of Anti-Cancer Immunotherapies. Cancers, 18(1), 123.
https://doi.org/10.3390/cancers18010123